Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02824822 · ClinicalTrials.gov registry record

Genetic Markers of Cardiovascular Disease in Epilepsy

A clinical trial of Epilepsy and Seizures, sponsored by Mayo Clinic.

Recruiting
Registry status
600
Enrollment target
1
Study location

NCT02824822 is a study of Epilepsy and Seizures that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 600 participants, below the 949-participant average among 160 other Epilepsy trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02824822, a study of Epilepsy and Seizures, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
600 participants
Enrollment target
1
Study location

Study Summary

Epilepsy is a common condition which affects over 3 million people in the US. Patients with uncontrolled epilepsy have a lifetime risk of sudden unexpected death (SUDEP) of 35%, which is greatest in those under 40 years of age. The exact mechanisms and causes are not understood but can be due to underlying conditions which affect the heart and brain, which may lead to dangerous heart rhythms and death. Some of these conditions which affect heart and brain have an identifiable genetic cause. This study aims to identify known genetic causes of heart rhythm and sudden death related disorders in patients with epilepsy.

Conditions Studied

Epilepsy Seizures Cardiomyopathies Syncope Channelopathy

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2016-05
Est. Completion 2031-12

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02824822

The ClinicalTrials.gov registry entry for NCT02824822 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 949-participant average among 160 other Epilepsy trials with a reported enrollment target (37% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Epilepsy appearing as the primary indexed condition, and to 0 interventions.

NCT02824822 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02824822 about?

NCT02824822 is a clinical study titled "Genetic Markers of Cardiovascular Disease in Epilepsy". Epilepsy is a common condition which affects over 3 million people in the US. Patients with uncontrolled epilepsy have a lifetime risk of sudden unexpected death (SUDEP) of 35%, which is greatest in those under 40 years of age. The exact mechanisms and causes are not understood but can be due to und...

What is the current status of trial NCT02824822?

This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2016-05. Estimated completion is 2031-12.

What conditions does trial NCT02824822 study?

This clinical trial studies the following conditions: Epilepsy, Seizures, Cardiomyopathies, Syncope, Channelopathy.

Who is sponsoring clinical trial NCT02824822?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02824822 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Epilepsy

All registered trials for this condition

Seizures

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.